George A. Scangos

Biography

  Dr. George A. Scangos, Ph.D., serves as the Chief Executive Officer and Director of Vir Biotechnology, Inc. since January 2017. Dr. Scangos served as the Chief Executive Officer of Biogen Idec Ltd. since July 2010 to 2016. He served as the Chief Executive Officer of Biogen Inc. from July 2010 to January 6, 2015. He served as the President and Chief Executive Officer of Exelixis, Inc., a holding company of X-ceptor Therapeutics Inc. from October 1996 to July 2010. He served as the President of Biotechnology of Bayer Corporation from September 1993 to October 1996 and was responsible for 1,100 employees in research and development, business development, process development, manufacturing, engineering and quality assurance. He worked 10 years at Bayer Corporation. He joined Bayer in 1987 as a Staff Scientist. At Bayer, he served in several positions, including Senior Vice President of Research and Development for Bayer's Pharmaceutical Division and then President of Bayer Biotechnology. He has nearly 25 years of experience in the biotechnology and pharmaceutical industries. He served as the Chairman of the California Healthcare Institute in 2010. He served as the Chairman of Anadys Pharmaceuticals Inc. from December 31, 2005 to 2010. He serves as the Vice Chairman of California Healthcare Institute (CHI) and California Life Sciences Association. He has been a Director of Decibel Therapeutics, Inc. since January 18, 2017, Agilent Technologies, Inc. since September 2014, Exelixis, Inc. since October 1996 and Biogen Idec Ltd. since July 2010. He serves as a Director of Vir Biotechnology, Inc., BayBio, Symphony Evolution, Inc., and Foundation Sante. He serves as a Member of Advisory Board at QB3. He served as an Independent Director at Anadys Pharmaceuticals Inc. since October 2003. He served as a Non Executive Director at Entelos, Inc. since September 1997. He served as a Director at Bay Area Bioscience Association. He served as a Director of Biogen Inc. from July 2010 to January 6, 2015. He served as a Director at Onyx Pharmaceuticals, Inc. from June 2000 to March 2005. He serves as an Adjunct Professor of Biology at Johns Hopkins University. He was a Professor of Biology at Johns Hopkins University for six years. He serves as a Member of the Boards of Trustees of the Boston Museum of Science and the Biomedical Science Careers Program and a Member of the National Board of Visitors of the University of California, Davis School of Medicine. He serves on the Board of Visitors at the University of California, San Francisco School of Pharmacy, the Board of Overseers at the University of California, Davis Medical School. He served as the Chairman of the Board of Directors at Pharmaceutical Research and Manufacturers of America (PhRMA) from March of 2016 to January of 2017. He was a Jane Coffin Childs Postdoctoral Fellow in the laboratory of Frank Ruddle at Yale University. He served as a Member of The Board of the Global Alliance for TB Drug Development until 2010. Dr. Scangos holds a B.A. in Biology from Cornell University and a Ph.D. in Microbiology from the University of Massachusetts.

Research Interest

  microbiology